800px-flag_of_the_peoples_republic_of_china

China to accelerate drug approvals with overseas trial data

October 9, 2017
Research and Development, Sales and Marketing China, drug approvals, pharma, pharmaceuticals

In a bid to speed up access to medicines for patients, China has revealed it intends to incorporate data from …

sleeping_man

Battery implant approved to treat sleep apnea

October 9, 2017
Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical

The FDA has announced the approval of a new form of treatment for central sleep apnea, in the form of …

Sanofi promotes global head of diabetes to expand role

October 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, biotech, diabetes, drugs, pharma, pharmaceutical

Sanofi has promoted Stefan Oelrich to the position of Executive Vice President of Diabetes and Cardiovascular (DCV), giving him a …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The week has flown by and was packed with a number of shocking stories. With the ongoing uncertainty regarding Brexit, …

androgel

AbbVie hit with $140m fine over fraudulent marketing of Androgel

October 6, 2017
Medical Communications, Sales and Marketing AbbVie, androgel, biotech, drugs, pharma, pharmaceutical

AbbVie has been stung with a $140 million damages award to a man that suffered a heart attack after using …

At least 40% of Afghanistan’s medicine imported illegally, union claims

October 6, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing afghanistan, pharma, pharmaceuticals

New damning allegations have arisen concerning Afghanistan’s pharmaceutical industry, as the Medicine Importers Union claims that at least 40% of …

bayer_cross_2

Bayer forced to halt huge study into key drug

October 6, 2017
Medical Communications, Research and Development Bayer, Janssen, Xarelto, biotech, drugs, pharma, pharmaceutical

Bayer, and development partner Janssen, have been forced to stop a Phase 3 trial looking at expanding the indication of …

aspen

South Africa’s over-charging case against Aspen dissolves, remains against big names

October 6, 2017
Medical Communications, Sales and Marketing Genentech, Pfizer, Roche, aspen, biotech, drugs, pharma, pharmaceutical

South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …

Merck KGaA promotes from within new MEA head

October 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA has installed a new head of its healthcare business for the Middle East, Africa and Turkey (MEA) region, …

shutterstock_92671375

UK High Court rejects ABPI’s challenge to new NICE cost curbs

October 5, 2017
Sales and Marketing ABPI, NHS, NHS England, NICE, legal, pharma, pharmaceutical

The ABPI has been knocked back by the UK High Court in its legal challenge to NICE over new drug …

culture

Gonorrhoea is just the tip of the antimicrobial resistance iceberg

October 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NovaBiotics, biotech, drugs, gonorrhoea, pharma, pharmaceutical

Dr Deborah O’Neil, Chief Executive and Scientific Officer at NovaBiotics, discusses the WHO-recognised threat of ‘super gonorrhoea’ and the antimicrobial …

fpr4et-xlarge_trans_nvbqzqnjv4bqrqsyshnmi5jqhkavocpkgbkoqxwcrp1qzr8w2tfjptk

England set to adopt opt-out organ donation

October 5, 2017
Medical Communications biotech, drugs, organ donation, pharma, pharmaceutical

In a major change for the healthcare system in England, admittedly one that was easy to be lost among the …

gilead-sciences

Gilead completes £11.9 billion Kite Pharma acquisition

October 5, 2017
Sales and Marketing CAR T, CAR-T, Gilead, Kite, acquisition, pharma, pharmaceuticals

Gilead has announced that it has completed its acquisition of Kite Pharma after the deal was announced on 28 August …

ema_interior

57% of cancer drugs uses approved by EMA show no benefit

October 5, 2017
Sales and Marketing EMA, biotech, drugs, oncology, pharma, pharmaceutical

A new study conducted by King’s College London and LSE has found that of 48 treatments approved between 2009 and …

mylan_building_3

Mylan receives shock approval of Teva blockbuster

October 5, 2017
Sales and Marketing Copaxone, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Mylan had been knocked back by the FDA in its quest to have its generic version of Copaxone approved earlier …

abbvie_0

AbbVie adds biologic production capability to Singapore facility

October 4, 2017
Manufacturing and Production, Research and Development AbbVie, Singapore, biologics, pharma, pharmaceuticals

AbbVie has expanded the operational capability of its facility located at the Tuas Biomedical Park in Singapore with the addition …

amgen_hq

CytomX scores deal with Amgen worth potential $1.5bn

October 4, 2017
Research and Development, Sales and Marketing Amgen, biotech, cytomx, drugs, pharma, pharmaceutical

CytomX Therapeutics and Amgen have signed a deal that could be worth a potential $1.5 billion. The agreement will see …

Police raid French HQ of Merck KGaA over thyroid drug scandal

October 4, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Levothyrox, Merck KGaA, hyperthyroidism, pharma, pharmaceuticals

Police have raided the French headquarters of German drug manufacturer Merck KGaA over a scandal concerning its thyroid treatment Levothyrox, …

cholera_infection_map

Global campaign to reduce cholera deaths by 90%

October 4, 2017
Medical Communications, Research and Development Cholera, WHO, biotech, drugs, pharma, pharmaceutical

A new campaign, launched by the WHO, has begun today to reduce deaths from cholera by 90% through to 2030. …

The Gateway to Local Adoption Series

Latest content